Patients for gastric bypass surgery should be carefully selected on the basis of several objective factors, and those chosen should be treated and monitored by specialized teams to optimize outcomes.
When patients and physicians disagree on the use of genetic engineering technology, physicians must act in accordance with professional ethics and society's guidelines.